X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Elder Pharma with Pfizer - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs PFIZER - Comparison Results

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA PFIZER ELDER PHARMA/
PFIZER
 
P/E (TTM) x -0.2 31.2 - View Chart
P/BV x 0.1 5.0 2.0% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 ELDER PHARMA   PFIZER
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
PFIZER
Mar-16
ELDER PHARMA/
PFIZER
5-Yr Chart
Click to enlarge
High Rs3802,724 14.0%   
Low Rs1881,611 11.7%   
Sales per share (Unadj.) Rs491.2440.9 111.4%  
Earnings per share (Unadj.) Rs-3.248.7 -6.5%  
Cash flow per share (Unadj.) Rs14.475.8 19.0%  
Dividends per share (Unadj.) Rs015.00 0.0%  
Dividend yield (eoy) %00.7 0.0%  
Book value per share (Unadj.) Rs376.5462.9 81.3%  
Shares outstanding (eoy) m20.5445.75 44.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.64.9 11.8%   
Avg P/E ratio x-89.344.5 -200.5%  
P/CF ratio (eoy) x19.728.6 68.9%  
Price / Book Value ratio x0.84.7 16.1%  
Dividend payout %030.8 0.0%   
Avg Mkt Cap Rs m5,83399,163 5.9%   
No. of employees `000NA2.9 0.0%   
Total wages/salary Rs m2,1792,758 79.0%   
Avg. sales/employee Rs ThNM6,981.7-  
Avg. wages/employee Rs ThNM954.5-  
Avg. net profit/employee Rs ThNM771.1-  
INCOME DATA
Net Sales Rs m10,08920,170 50.0%  
Other income Rs m257857 29.9%   
Total revenues Rs m10,34621,028 49.2%   
Gross profit Rs m-7924,310 -18.4%  
Depreciation Rs m3611,239 29.2%   
Interest Rs m2,7565 53,005.8%   
Profit before tax Rs m-3,6533,923 -93.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,71399 3,755.1%   
Tax Rs m1251,794 7.0%   
Profit after tax Rs m-652,228 -2.9%  
Gross profit margin %-7.821.4 -36.7%  
Effective tax rate %-3.445.7 -7.5%   
Net profit margin %-0.611.0 -5.9%  
BALANCE SHEET DATA
Current assets Rs m9,24016,299 56.7%   
Current liabilities Rs m9,9987,594 131.7%   
Net working cap to sales %-7.543.2 -17.4%  
Current ratio x0.92.1 43.1%  
Inventory Days Days4665 70.9%  
Debtors Days Days6026 232.8%  
Net fixed assets Rs m10,1248,622 117.4%   
Share capital Rs m206458 45.0%   
"Free" reserves Rs m5,58220,722 26.9%   
Net worth Rs m7,73421,180 36.5%   
Long term debt Rs m4,88925 19,556.0%   
Total assets Rs m22,88229,137 78.5%  
Interest coverage x-0.3755.5 -0.0%   
Debt to equity ratio x0.60 53,558.4%  
Sales to assets ratio x0.40.7 63.7%   
Return on assets %11.87.7 153.5%  
Return on equity %-0.810.5 -8.0%  
Return on capital %22.319.0 117.5%  
Exports to sales %3.00.1 5,108.0%   
Imports to sales %0.417.5 2.4%   
Exports (fob) Rs m30712 2,555.0%   
Imports (cif) Rs m433,526 1.2%   
Fx inflow Rs m30752 593.6%   
Fx outflow Rs m125140 89.5%   
Net fx Rs m181-88 -205.3%   
CASH FLOW
From Operations Rs m11,7543,436 342.1%  
From Investments Rs m-561-6,991 8.0%  
From Financial Activity Rs m-6,762-619 1,092.7%  
Net Cashflow Rs m4,432-4,174 -106.2%  

Share Holding

Indian Promoters % 39.6 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 7.5 7.5 100.0%  
FIIs % 16.8 4.9 342.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 23.7 152.3%  
Shareholders   16,479 85,207 19.3%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   ALEMBIC LTD  SUN PHARMA  PIRAMAL ENTERPRISES  FDC LTD.  AUROBINDO PHARMA  

Compare ELDER PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue to Fall, IT Sector Growth Projections, and Top Stocks in Action(Pre-Open)

On Wednesday, share markets in India opened in green but ended on a weak note. The BSE Sensex closed lower by 71 points to end the day at 33,704.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 5-YR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS